tuftsin has been researched along with Giant Cell Arteritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belloni, L; Blank, M; Boiardi, L; Bonacini, M; Caruso, A; Cavazza, A; Cimino, L; Croci, S; Fontana, A; Fridkin, M; Muratore, F; Parmeggiani, M; Perry, O; Salvarani, C; Shoenfeld, Y; Soriano, A | 1 |
1 other study(ies) available for tuftsin and Giant Cell Arteritis
| Article | Year |
|---|---|
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cell Differentiation; Cells, Cultured; Cytokines; Dexamethasone; Drug Combinations; Female; Giant Cell Arteritis; Humans; Immunotherapy; Lymphocyte Activation; Male; Phosphorylcholine; T-Lymphocyte Subsets; Th1 Cells; Tuftsin | 2019 |